Who makes Qinqiao Yanshu Granules?

Qinqiao Yanshu Granules is developed by Jianmin Pharmaceutical Group Co., LTD..

What development phase is Qinqiao Yanshu Granules in?

Qinqiao Yanshu Granules is in Phase 2.

Last reviewed 2026-04-19 · How we verify

Qinqiao Yanshu Granules

Jianmin Pharmaceutical Group Co., LTD. · Phase 2 active Small molecule

At a glance

Generic name	Qinqiao Yanshu Granules
Sponsor	Jianmin Pharmaceutical Group Co., LTD.
Modality	Small molecule
Phase	Phase 2

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Qinqiao Yan Shu Granules for the Treatment of Acute Pharyngitis (Exterior Wind-Heat Syndrome) Phase II Clinical Trial (PHASE2)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Qinqiao Yanshu Granules CI brief — competitive landscape report
Qinqiao Yanshu Granules updates RSS · CI watch RSS
Jianmin Pharmaceutical Group Co., LTD. portfolio CI